Viking Therapeutics (VKTX) Return on Capital Employed Growth (5y) (2020 - 2026)
Viking Therapeutics (VKTX) Return on Capital Employed Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Viking Therapeutics | 4.10 Bn | 4.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,123.00 |
| Dec 31, 2025 | -4,322.00 |
| Sep 30, 2025 | -2,065.00 |
| Jun 30, 2025 | -1,182.00 |
| Mar 31, 2025 | -632.00 |
| Dec 31, 2024 | -519.00 |
| Sep 30, 2024 | -383.00 |
| Jun 30, 2024 | -281.00 |
| Mar 31, 2024 | -850.00 |
| Dec 31, 2023 | -1,957.00 |
| Sep 30, 2023 | -1,361.00 |
| Jun 30, 2023 | -1,141.00 |
| Mar 31, 2023 | -905.00 |
| Dec 31, 2022 | 18,083.00 |
| Sep 30, 2022 | 49,113.00 |
| Jun 30, 2022 | 20,738.00 |
| Mar 31, 2022 | 10,554.00 |
| Dec 31, 2021 | 12,805.00 |
| Sep 30, 2021 | 10,495.00 |
| Jun 30, 2021 | 13,689.00 |